<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04701398</url>
  </required_header>
  <id_info>
    <org_study_id>PI19/0037</org_study_id>
    <nct_id>NCT04701398</nct_id>
  </id_info>
  <brief_title>Multimodal Prehabilitation in Frail and Non-frail Patients Waiting for a Kidney Transplantation (the FRAILMAR Study)</brief_title>
  <acronym>Frailmar</acronym>
  <official_title>Frailty in Patients With Advanced Chronic Kidney Disease Waiting for a Kidney Transplantation. A Randomized Clinical Trial of Multimodal Prehabilitation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parc de Salut Mar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Frailty is very frequent among patients waiting for a kidney transplantation (KT). Frailty&#xD;
      and poor fitness powerfully predict mortality, kidney graft survival, and healthcare&#xD;
      utilization after KT. Frailty in patients with chronic kidney disease (CKD) displays a&#xD;
      constellation of features that characterize a special population. Intervention is essential&#xD;
      to improve quality of life for frail CKD patients, regardless of their age. A pre-transplant&#xD;
      intervention including physical therapy, nutritional measures and psychological support&#xD;
      scheduled for before the transplant may improve patient retention and compliance, better&#xD;
      mitigate the effects of frailty and poor fitness after KT, and improve main outcomes in frail&#xD;
      CKD patients.&#xD;
&#xD;
      The main objective is to assess effectiveness, feasibility and safety of a prehabilitation&#xD;
      program (exercise, nutritional plans, psychological advice) in frail and non-frail KT&#xD;
      candidates on clinical and functional outcomes after KT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Frailty is very frequent among patients with chronic kidney disease (CKD) included in the&#xD;
      waiting list for deceased donor kidney transplantation (KT), and outcomes are worsened in&#xD;
      those frail recipients after KT. Frailty and poor fitness powerfully predict mortality,&#xD;
      kidney graft survival, and healthcareutilization after KT. Frailty in CKD patients displays a&#xD;
      unique constellation of features such as muscle wasting, anorexia, protein energy wasting,&#xD;
      inflammation, oxidative stress, catabolic/anabolic hormone imbalance, metabolic acidosis, and&#xD;
      other cellularalterations that characterize a special population. Intervention is essential&#xD;
      to improve quality of life for frail CKD patients, regardless of their age. Efforts to&#xD;
      intervene with post- transplant physical therapy have been met with limited success, in large&#xD;
      part due to high study dropout. A pre-transplant clinical framework for multimodal&#xD;
      prehabilitation interventions including physicaltherapy, nutritional measures and&#xD;
      psychological support scheduled for before the transplant may improve patient retention&#xD;
      andcompliance, better mitigate the effects of frailty and poor fitness after KT, and improve&#xD;
      main outcomes in frail CKD patients.&#xD;
&#xD;
      The main objective of this study is to assess effectiveness, feasibility and safety of&#xD;
      multimodal prehabilitation (exercise, nutritional plans, psychological advice) in frail and&#xD;
      non-frail KT candidates in the context of a randomized controlled clinical trial. The primary&#xD;
      endpoint will be a composite achievement of clinical and functional outcomes in frail and&#xD;
      non-frail KT candidates after KT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Clinical Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bad-Outcome Composite Endpoint</measure>
    <time_frame>90 days post-kidney transplantation</time_frame>
    <description>Delayed draft function &gt;14 days + never functioning kidney + non-elective readmission before day 90 + surgical complications (wound healing problems, obstructive lymphocele, vascular thrombosis, urinary stenosis or leak, acute hemorrhage, immediate re-intervention) + discharge to an assisted facility + all-cause death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in exercise capacity</measure>
    <time_frame>Post-intervention (12 weeks)</time_frame>
    <description>Changes in peak oxygen uptake (higher scores mean better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in peripheral muscle strength</measure>
    <time_frame>Post-intervention (12 weeks)</time_frame>
    <description>Changes in handgrip and quadriceps muscles strength (higher scores mean better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in respiratory muscle strength</measure>
    <time_frame>Post-intervention (12 weeks)</time_frame>
    <description>Changes in maximal inspiratory and expiratory muscle strength (higher scores mean better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in physical activity</measure>
    <time_frame>Post-intervention (12 weeks)</time_frame>
    <description>Changes in physical activity assessed by activity monitors (higher scores mean better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attendance</measure>
    <time_frame>Post-intervention (12 weeks)</time_frame>
    <description>Attended sessions (0-100%, patients are expected to attend a minimum of 80% sessions)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise tolerability</measure>
    <time_frame>Post-intervention (12 weeks)</time_frame>
    <description>Patients not requiring exercise discontinuation or intensity modification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in muscle mass</measure>
    <time_frame>1 month post-KT</time_frame>
    <description>Changes in muscle mass assessed with total body dual energy X-ray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in mood state</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Changes in Hospital Anxiety Depression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in health-related quality of life</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Score in the Short-Form 36 questionnaire (8 dimensions scoring 0-100, higher scores mean better outcomes)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Multimodal intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>supervised physical training (1-hour sessions, 24 sessions, 8 weeks) + nutritional supplementation + psychological advice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Healthy living recommendations</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multimodal prehabilitation</intervention_name>
    <description>Exercise + nutritional supplementation + psychological advice</description>
    <arm_group_label>Multimodal intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults patients with chronic kidney disease&#xD;
&#xD;
          -  Inclusion in the waiting list for deceased donor kidney transplantation in the period&#xD;
             September 2020 to August 2022&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to perform the exercise plan or giving informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julio Pascual Santos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Parc de Salut Mar</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ester Marco, MD</last_name>
    <phone>+34699706860</phone>
    <email>emarco@psmar.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ester Marco, MD PhD</last_name>
      <phone>+34699706860</phone>
      <email>emarco@parcdesalutmar.cat</email>
    </contact>
    <investigator>
      <last_name>Julio Pascual Santos, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ester Marco, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria-José Pérez Saez, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Faura Vendrell, Ns</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Benito Guasch, Ns</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Vera Casanova, Ns</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Bach Pascual, Ns</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Montserrat Folgueiras López, Ns</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria D Muns Cornellas, Nutritionist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olga Vázquez Ibar, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Garriz Vera, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Polo Gómez, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 5, 2021</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic kidney disease</keyword>
  <keyword>kidney transplantation</keyword>
  <keyword>frailty</keyword>
  <keyword>prehabilitation</keyword>
  <keyword>exercise</keyword>
  <keyword>nutritional status</keyword>
  <keyword>psychological advice</keyword>
  <keyword>sarcopenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

